Acquired epidermodysplasia verruciformis: clinical presentation and treatment update

Acquired epidermodysplasia verruciformis (AEV) is a form of epidermodysplasia verruciformis (EV) that is most commonly found in immunocompromised or immunosuppressed patients. EV is commonly associated with human papillomavirus (HPV), which is often found in EV and AEV lesions. Clinical presentation of AEV in patients with organ transplantation, HIV+, congenital HIV+, hematological diseases, and other iatrogenic immunosuppression are reviewed. Treatment options include topical cidofovir, topical retinoids, topical imiquimod, topical glycolic acid, HPV 9‐valent vaccine, acitretin, improving cellular immunity, and changing transplant medication to mycophenolate mofetil.

[1]  R. Sijmons,et al.  Acquired Human Papilloma Virus Type 6-Associated Epidermodysplasia Verruciformis in a Patient With Systemic Lupus Erythematosus. , 2020, The American Journal of dermatopathology.

[2]  J. Weaver,et al.  Acquired Epidermodysplasia Verruciformis in the Setting of Renal Transplant. , 2020, The American Journal of dermatopathology.

[3]  H. Doan,et al.  Acquired epidermodysplasia verruciformis: a 10‐year anniversary update , 2020, The British journal of dermatology.

[4]  S. Tyring,et al.  Verrucous lesions in an HIV-positive man , 2019, JAAD case reports.

[5]  M. Sotto,et al.  Epidermodysplasia verruciformis: revision of a model of carcinogenic disease , 2019, Surgical and Experimental Pathology.

[6]  B. Thyagarajan,et al.  Diagnosis of epidermodysplasia verruciformis: Two cases highlighting the role of direct HPV L1 gene sequencing , 2019, Journal of cutaneous pathology.

[7]  S. Shete,et al.  A call for the introduction of gender-neutral HPV vaccination to national immunisation programmes in Africa. , 2019, The Lancet. Global health.

[8]  C. Nguyen,et al.  Acquired epidermodysplasia verruciformis in setting of tumor necrosis factor-α inhibitor therapy , 2018, JAAD case reports.

[9]  S. Tyring,et al.  A novel approach to the classification of epidermodysplasia verruciformis , 2018, International journal of dermatology.

[10]  C. Kovarik,et al.  Malignant degeneration of diffuse intertriginous flat warts in a patient with AIDS , 2018, JAAD case reports.

[11]  S. Tabrizi,et al.  A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination , 2018, The Australasian journal of dermatology.

[12]  B. Amin,et al.  Acquired Epidermodysplasia Verruciformis and Its Relationship to Immunosuppressive Therapy: Report of a Case and Review of the Literature. , 2017, Journal of drugs in dermatology : JDD.

[13]  J. Guitart,et al.  Eccrine Syringofibroadenoma in Association With Acquired Epidermodysplasia Verruciformis. , 2017, The American Journal of dermatopathology.

[14]  Y. Ramot,et al.  Re‐evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate , 2017, Journal of the American Academy of Dermatology.

[15]  E. Hossler,et al.  Acquired epidermodysplasia verruciformis occurring in a renal transplant recipient. , 2017, Cutis.

[16]  Qiang Sun,et al.  The Papillomavirus Episteme: a major update to the papillomavirus sequence database , 2016, Nucleic Acids Res..

[17]  Carmen Lau,et al.  Acquired epidermodysplasia verruciformis in an HIV-positive patient , 2016, International journal of STD & AIDS.

[18]  S. Tyring,et al.  Acquired Epidermodysplasia Verruciformis Associated with Human Papilloma Virus Type 14 in a Small Bowel Transplanted Child—A Case Report , 2016, Pediatric dermatology.

[19]  S. Tyring,et al.  Cornoid Lamella-Like Structures in HIV-Associated Epidermodysplasia Verruciformis: A Unique Histopathologic Finding , 2015, The American Journal of dermatopathology.

[20]  L. Ysebaert,et al.  Acquired epidermodysplasia verruciformis, a new opportunistic infection related to bendamustine , 2015, Annals of Hematology.

[21]  M. Kirchhof,et al.  Brazilian waxing and human papillomavirus: a case of acquired epidermodysplasia verruciformis , 2015, Canadian Medical Association Journal.

[22]  S. Tyring,et al.  Acquired Epidermodysplasia Verruciformis in a Child with Atopic Dermatitis , 2014, Pediatric dermatology.

[23]  R. Epstein,et al.  Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control. , 2014, Cancer treatment reviews.

[24]  Alena Margareth Darwich Mendes,et al.  Acquired epidermodysplasia verruciformis in a renal transplant recipient - Case report* , 2014, Anais brasileiros de dermatologia.

[25]  M. Tollefson,et al.  Acquired Epidermodysplasia Verruciformis in a Child with the Human Immunodeficiency Virus , 2013, Pediatric dermatology.

[26]  L. Mazzuoccolo,et al.  Acquired Epidermodysplasia Verruciformis in a Patient With Congenital HIV Infection , 2013 .

[27]  D. Linder,et al.  Acquired Epidermodysplasia Verruciformis: A Comprehensive Review and a Proposal for Treatment , 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[28]  R. Nijhawan,et al.  Sustained clinical resolution of acquired epidermodysplasia verruciformis in an immunocompromised patient after discontinuation of oral acitretin with topical imiquimod. , 2013, Journal of drugs in dermatology : JDD.

[29]  C. Muñoz-Almagro,et al.  High-risk alpha-human papillomavirus types: detection in HIV-infected children with acquired epidermodysplasia verruciformis. , 2013, Journal of the American Academy of Dermatology.

[30]  S. Tyring,et al.  Epidermodysplasia verruciformis associated with HPV 10. , 2013, Dermatology online journal.

[31]  H. Bangash,et al.  Management of Non-Melanoma Skin Cancer in Immunocompromised Solid Organ Transplant Recipients , 2012, Current Treatment Options in Oncology.

[32]  C. Bunker,et al.  Acquired Epidermodysplasia Verruciformis Due to Multiple and Unusual HPV Infection Among Vertically-Infected, HIV-Positive Adolescents in Zimbabwe , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  C. Kovarik,et al.  Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterization. , 2012, Archives of dermatology.

[34]  J. Klaustermeier,et al.  New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir. , 2011, Journal of the American Academy of Dermatology.

[35]  C. Elmets,et al.  Procarcinogenic effects of cyclosporine A are mediated through the activation of TAK1/TAB1 signaling pathway. , 2011, Biochemical and biophysical research communications.

[36]  J. Toribio,et al.  Epidermodisplasia verruciforme adquirida en una paciente transplantada renal , 2011 .

[37]  K. Mertz,et al.  Detection of Merkel Cell Polyomavirus in Epidermodysplasia-Verruciformis-Associated Skin Neoplasms , 2010, Dermatology.

[38]  Kachiu C. Lee,et al.  What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients? , 2010, Archives of dermatology.

[39]  C. Talhari,et al.  Post-ART Epidermodysplasia Verruciformis in a Patient With AIDS , 2010, Journal of the International Association of Physicians in AIDS Care.

[40]  S. Tyring,et al.  Acquired epidermodysplasia verruciformis. , 2009, Journal of the American Academy of Dermatology.

[41]  A. Bruckner,et al.  Epidermodysplasia verruciform-like Lesions in an HIV patient. , 2009, Dermatology online journal.

[42]  G. Papatheodorou,et al.  Systemic low‐dose isotretinoin maintains remission status in epidermodysplasia verruciformis , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[43]  Yan Wang,et al.  Epidermodysplasia Verruciformis with severe hand and foot deformity successfully treated with surgical excision. , 2008, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[44]  A. Katsambas,et al.  Genital HPV Lesions and Molluscum Contagiosum Occurring in Patients Receiving Anti-TNF-α Therapy , 2008, Dermatology.

[45]  A. Lazar,et al.  Epidermodysplasia verruciformis in the setting of graft-versus-host disease. , 2007, Journal of the American Academy of Dermatology.

[46]  A. Bassolé,et al.  [Epidermodysplasia verruciformis: clinicaland epidemiological features of 45 cases in the Department of Dermatology at the University Hospital Center of Yalgado Ouedraogo, Ouagadougou]. , 2007, Dakar medical.

[47]  C. Morrison,et al.  The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients , 2002, Journal of cutaneous pathology.

[48]  N. Prose,et al.  Widespread flat warts associated with human papillomavirus type 5: a cutaneous manifestation of human immunodeficiency virus infection. , 1990, Journal of the American Academy of Dermatology.